|
Originally published In Press as doi:10.1074/jbc.M105206200 on August 24, 2001
J. Biol. Chem., Vol. 276, Issue 43, 40306-40312, October 26, 2001
Discovery and Structure of a Potent and Highly Specific
Blocker of Insect Calcium Channels*
Xiu-hong
Wang ,
Mark
Connor§,
David
Wilson¶,
Harry I.
Wilson ,
Graham M.
Nicholson ,
Ross
Smith**,
Denis
Shaw ,
Joel P.
Mackay§§,
Paul F.
Alewood¶,
Macdonald
J.
Christie§, and
Glenn F.
King ¶¶
From the Department of Biochemistry, University of
Connecticut Health Center, Farmington, Connecticut 06032, Departments
of § Pharmacology and
§§ Biochemistry, University of Sydney, Sydney,
New South Wales 2006, Australia, ¶ Institute for Molecular
Bioscience and ** Department of Biochemistry, University of
Queensland, Brisbane, Queensland 4072, Australia, Department
of Health Sciences, University of Technology, Sydney, New South
Wales 2007, Australia, and  John Curtin
School of Medical Research, Australian National University, Canberra,
Australian Capital Territory 0200, Australia
Received for publication, June 6, 2001, and in revised form, August 21, 2001
 |
ABSTRACT |
We have isolated a novel family of
insect-selective neurotoxins that appear to be the most potent blockers
of insect voltage-gated calcium channels reported to date. These toxins
display exceptional phylogenetic specificity, with at least a
10,000-fold preference for insect versus vertebrate calcium
channels. The structure of one of the toxins reveals a highly
structured, disulfide-rich core and a structurally disordered
C-terminal extension that is essential for channel blocking activity.
Weak structural/functional homology with -agatoxin-IVA/B, the
prototypic inhibitor of vertebrate P-type calcium channels, suggests
that these two toxin families might share a similar mechanism of action
despite their vastly different phylogenetic specificities.
 |
INTRODUCTION |
New methods of insect control are urgently required due to
the evolution of insect resistance to classical chemical pesticides (1), growing appreciation of the environmental damage caused by many
agrochemicals, and increased public concern about the human health
risks associated with prolonged insecticide exposure (2). One promising
approach is to engineer plants to produce insect-specific toxins, as
exemplified by the engineering of genes encoding insecticidal toxins
from the soil bacterium Bacillus thuringiensis into a
variety of agricultural cultivars (3). A potentially more selective
method is to use insect-specific viruses as vectors to deliver toxins
to a restricted number of target insects without harming non-target
animals (4, 5).
Unfortunately, there are few well characterized peptide/protein toxins
that lend themselves to these genomic approaches. Spider venoms can be
viewed as preoptimized combinatorial libraries of insecticidal
peptides, and therefore we decided to exploit these venoms in the
search for insect-specific toxins suitable for engineering into plants and insect viruses. Here we describe a new family of
insecticidal neurotoxins isolated by screening the venom of the lethal
Australian funnel-web spider Hadronyche versuta (Fig. 1,
inset). These toxins are the most potent blockers of insect voltage-gated calcium channels reported to date, but they are virtually
inactive on vertebrate ion channels, making them ideal biopesticide
candidates. The structure of one of the toxins reveals a compact,
disulfide-rich core and a structurally disordered lipophilic extension
that is essential for channel blocking activity.
 |
EXPERIMENTAL PROCEDURES |
Purification of Toxins--
Funnel-web spiders were collected
from the Blue Mountains west of Sydney (H. versuta), from
Fraser Island, Queensland (H. infensa), and from the
Illawarra region of New South Wales (Atrax sp.
Illawarra). Lyophilized crude venom was fractionated using a
Vydac C18 analytical reverse phase high pressure liquid
chromatography (rpHPLC)1
column as described previously (6). Semi-pure -ACTX-Hv2a obtained
from this initial fractionation was further purified on the same column
using a gradient of 30-48% acetonitrile over 35 min at a flow rate of
1 ml min 1. Once purified to >98% homogeneity, peptides
were lyophilized and stored at 20 °C until further use. Cysteine
residues were alkylated before sequencing (7).
Insect and Vertebrate Toxicity Assays--
Insecticidal activity
was tested by injecting peptides into house crickets (Acheta
domesticus Linnaeus) as described previously (7). Vertebrate
activity was assayed as described previously (8) using vertebrate
smooth (vas deferens) and skeletal (biventer cervicis) nerve-muscle
preparations; tissue contractions were recorded in the absence of
additives or after injection of peptides directly into the bath buffer.
-Atracotoxin-Hv1a (100 nM), a modulator of voltage-gated
sodium channels (9), was used as a positive control. Vertebrate
toxicity was determined by subcutaneous injection of -ACTX-Hv2a in
0.1 ml of saline into young BALB/c mice (3.1 ± 0.2 g;
n = 3). Toxicity was monitored over 72 h.
Preparation of cDNA Libraries and RACE Analysis--
Venom
glands were dissected from a single subdued specimen of H. infensa (mature female) and Atrax sp. Illawarra (mature
male), and mRNA was immediately isolated using a QuickPrep Micro
mRNA Purification Kit (Amersham Pharmacia Biotech). For the
H. infensa mRNA template, first-strand cDNA
synthesis employed Superscript II reverse transcriptase (Life
Technologies, Inc.) to extend a 3' universal poly(dT) anchor primer
(NotI-dT18; Amersham Pharmacia Biotech).
Second-strand synthesis used DNA polymerase I. Marathon adapters
(CLONTECH) were then ligated to the cDNA ends.
For the Atrax template, full-length single-stranded
cDNAs were obtained by including a 5' SMART II oligonucleotide
(CLONTECH) in addition to the
NotI-dT18 primer.
5'-RACE of the H. infensa cDNA library employed a
redundant primer based on the partial N-terminal sequence of
mature toxin (5'-(AGTC)GT(AG)TT(AGTC)AC(AGTC)AC(AG)CA(AG)TC) and a 5'
universal adapter primer (CLONTECH). Cloning and
sequencing of the derived leader sequence allowed a gene-specific
3'-RACE primer (5'- gtggacgccATGAAATTTTCAAAGC) to be designed
based on the 5'-untranslated region, translation start site, and
N-terminal signal sequence. This gene-specific primer was used in
conjunction with a 3' universal primer (Pacific Oligos) to amplify
entire coding sequences from both the H. infensa and
Atrax cDNA libraries. Final polymerase chain reaction
products (450-470 base pairs) were purified, cloned, and sequenced.
Electrophysiology--
Neurons were dissociated from brains of
adult European honeybees (Apis mellifera) as described
previously (6). Adult C57B16/J mice of either sex were anesthetized
with halothane and then killed by cervical dislocation. Trigeminal
ganglion neurons were isolated by gentle trituration of the minced
ganglia after a 20-min treatment at 34 °C with papain (20 units/ml 1) in a HEPES-buffered saline solution of 140 mM NaCl, 2.5 mM KCl, 2.5 mM
CaCl2, 1.5 mM MgCl2, 10 mM HEPES, and 10 mM glucose, pH 7.3 (HBS).
Standard whole cell voltage clamp recordings (10) were made of bee
brain calcium channel (ICa), sodium channel
(INa), and potassium channel
(IK) currents and mouse sensory neuron
ICa and INa at ambient
temperature (22 °C 24 °C). For bee neurons, recordings were made
with fire-polished borosilicate pipettes of ~6 megaohm resistance
when filled with an intracellular solution of either of the following
compositions: (a) 120 mM CsCl, 5 mM
NaCl, 5 mM MgATP, 0.3 mM Na2GTP, 10 mM EGTA, 2 mM CaCl2, and 10 mM HEPES, pH 7.3 (for INa and
ICa), or (b) 130 mM KF,
10 mM EGTA, 2 mM CaCl2, and 10 mM HEPES, pH 7.3 (for IK). For
recordings of ICa and
INa, the external solution consisted of 135 mM NaCl, 20 mM tetraethylammonium chloride, 5 mM CsCl, 5 mM BaCl2, 10 mM HEPES, 10 mM glucose, and 0.05% bovine
serum albumin, pH 7.3. For IK recording, the
external solution consisted of 130 mM NaCl, 20 mM KCl, 2.5 mM CaCl2, 1.5 mM MgCl2, 10 mM HEPES, 10 mM glucose, and 0.05% bovine serum albumin, pH 7.3. The
same internal solution was used for recordings of mouse sensory neuron
ICa and INa; electrodes
had a resistance of 1-2 megaohms. ICa external
solution contained 140 mM tetraethylammonium chloride, 2.5 mM CaCl2, 2.5 mM CsCl, 10 mM HEPES, 10 mM glucose, and 0.05% bovine
serum albumin, pH 7.3, whereas INa was recorded in HBS.
Neurons were voltage clamped at 90 mV, and currents were evoked by
stepping the membrane potential from 60 to +60 mV. Toxin effects on
ICa and INa were tested
at the potential with the largest inward current, usually 10 or 0 mV.
In bee neurons, the peak inward currents were usually abolished by 100 µM Cd2+, suggesting that the current was
largely carried by Ca2+ channels. In a few bee neurons,
there was a rapidly activating, transient, and
Cd2+-insensitive current that was blocked completely by
tetrodotoxin (1 µM). In mouse sensory neurons, the peak
inward currents evoked in the presence of potassium and sodium channel
blockers were abolished by 30 µM Cd2+. The
inward currents recorded in HBS consisted of both
tetrodotoxin-sensitive and tetrodotoxin-resistant components. Toxin
effects on bee brain IK were determined over a
range of membrane potentials (from 40 to +60 mV). Data were collected
and analyzed as described previously (11).
Folding and Purification of Truncated -ACTX-Hv2a--
A
synthetic peptide (90% purity) encompassing residues 1-32 of
-ACTX-Hv2a was purchased from Auspep (Melbourne, Australia). The
reduced peptide (referred to hereafter as CT-Hv2a) was oxidized/folded at ambient temperature (22 °C) in a glutathione redox buffer that promotes disulfide oxidation/shuffling (12). After 48 h, the reaction mixture was quenched with HCl and dialyzed against
H2O using 1-kDa cutoff cellulose dialysis tubing (Membrane
Filtration Products) to remove folding buffer components. The
lyophilized dialysate was dissolved in H2O and then applied
to a Vydac C18 analytical rpHPLC column; fully oxidized
CT-Hv2a was eluted with a retention time of 19 min using a gradient of
22-47% acetonitrile over 30 min at a flow rate of 1 ml
min 1.
NMR Spectroscopy--
NMR samples were prepared by dissolving
2.0 mg of -ACTX-Hv2a or 3.0 mg of synthetic CT-Hv2a in 260 µl of
either 7.5% or 100% D2O in a susceptibility-matched
microcell (Shigemi) and then adjusting the pH to 4.71. NMR spectra were
recorded at 288 K and 296 K using either a Bruker AVANCE or Varian
INOVA 600 MHz spectrometer. The following two-dimensional spectra were
recorded for both peptides in 7.5% D2O: TOCSY
( m = 70 ms) and NOESY with m = 60 ms
( -ACTX-Hv2a, 296 K), 250 ms ( -ACTX-Hv2a, 288 K), or 300 ms
( -ACTX-Hv2a and CT-Hv2a, 296 K). The following two-dimensional
spectra were recorded for the 100% D2O samples: ECOSY
( -ACTX-Hv2a only) and NOESY with m = 300 ms.
Spectra were processed using XWINNMR (Bruker) or Felix97 (Molecular
Simulations, Inc). Chemical shift assignments were made using XEASY
(13) and have been deposited in BioMagResBank (BMRB accession code
4923). Hydrogen bonds were identified using hydrogen-deuterium exchange
experiments (6).
Structure Calculations--
NOESY cross-peaks were integrated in
XEASY and converted to distance restraints (with pseudoatoms where
appropriate) using CALIBA (14). Dihedral-angle restraints were derived
as described previously (6). The intense intraresidue
H HN NOE for Arg-26, combined with a
3JHNH value of ~7 Hz, allowed its angle to be restrained to 50 ± 40° for both peptides (15).
H stereospecific assignments and 1
restraints for -ACTX-Hv2a were obtained using ECOSY-derived 3J coupling constants in combination with
H H and HN H
NOE intensities measured from the 60-ms NOESY spectrum. Proline
H protons were stereospecifically assigned as described previously (6). All X-Pro peptide bonds were clearly identified as
trans on the basis of characteristic NOEs (16). The
disulfide bonding pattern was determined unequivocally from preliminary structure calculations.
The torsion angle dynamics program DYANA was used to calculate 5000 structures from random starting conformations. The best 100 structures
(selected on the basis of final penalty-function values) were then
refined in X-PLOR (17). The 20 lowest-energy X-PLOR conformers were
used to represent the solution structures of -ACTX-Hv2a and CT-Hv2a.
MOLMOL (18) was used for molecular graphics.
 |
RESULTS |
Isolation of a Novel Insecticidal Toxin--
Fig.
1a shows a typical rpHPLC
fractionation of crude venom from H. versuta. 50 fractions
were individually assayed for insect and vertebrate toxicity. The
late-eluting peak marked with an arrow caused immediate and
sustained paralysis when injected into crickets (PD50 = 160 ± 9 pmol g 1; mean duration of paralysis at a
dose of 250-500 pmol g 1 = 4-5 h). Injection of crickets
with a second dose (250-500 pmol g 1) of toxin before
reversal of paralysis was lethal. The toxin was inactive in vertebrate
smooth and skeletal nerve-muscle preparations at a concentration of 1 µM (data not shown). These two neuromuscular preparations
were chosen for the vertebrate toxicity screen because in combination
they contain most of the potential neuropharmacological targets of
spider toxins such as ligand- and voltage-gated ion channels. As
further evidence of its lack of vertebrate toxicity, the toxin did not
cause any adverse effects when injected into newborn mice at doses of
up to 800 pmol g 1, which is 5-fold higher than the
PD50 in crickets.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 1.
Purification and primary structure of
-atracotoxin-Hv2a. a, rpHPLC
chromatogram of whole H. versuta venom. The
arrow indicates the retention time of the insect-specific
toxin -ACTX-Hv2a. The inset shows a female specimen of
H. versuta in an aggressive/defensive "ready-to-strike"
stance with forelegs and palps raised and fangs exposed. b,
comparison of primary structures of -atracotoxins from H. versuta ( -ACTX-Hv2a), H. infensa ( -ACTX-Hi2a and
-ACTX-Hi2b), and Atrax sp. Illawarra ( -ACTX-As2a and
-ACTX-As2b). The -ACTX-Hv2a sequence was derived from protein
sequencing, whereas the other primary structures are inferred from
cDNA sequences (see the text). Residues boxed in yellow
are identical in four or more of the sequences, whereas the strictly
conserved cysteine residues are highlighted in red. The
signal, propeptide, and mature peptide regions of the prepropeptide are
indicated, and the percentage of amino acid identity within each of
these regions is given in parentheses. The red arrowhead
marks the site of additional C-terminal processing of the H. infensa toxins (see the text). The secondary structure of
-ACTX-Hv2a, as determined in the current study, is shown
below the sequences ( -strands and 310-helices
are depicted as arrows and cylinders,
respectively).
|
|
Proteolytic digestion combined with N- and C-terminal sequencing
revealed the complete amino acid sequence of this 45-residue toxin
(Fig. 1b). Consistent with its long rpHPLC retention time, the toxin contains an unusually high proportion (55%) of apolar residues, including a highly hydrophobic C-terminal tail. We named the
peptide -ACTX-Hv2a (Swiss-Prot accession number P82852) based on its
molecular target (see below) and published nomenclature rules (11). The
toxin has no homologs in the protein/DNA sequence data bases.
Elucidation of Precursor Structure--
A peptide with a rpHPLC
retention time similar to that of -ACTX-Hv2a was also evident in the
venom of H. infensa. However, despite several attempts,
N-terminal sequencing yielded only 12 residues (GVLDCVVNTLGC), and
C-terminal sequencing indicated that the peptide had a blocked C
terminus. Hence, we used RACE analysis (19) to extract the complete
mRNA sequences corresponding to this toxin using cDNA libraries
prepared from the venom glands of H. infensa and
Atrax sp. Illawarra (see "Experimental Procedures").
Sequencing of RACE-derived clones revealed two 306-base pair coding
sequences from H. infensa (corresponding to two 102-residue translation products, -ACTX-Hi2a and -ACTX-Hi2b) and two 300-base pair coding sequences from the Atrax species (corresponding
to two 100-residue translation products, -ACTX-As2a and
-ACTX-As2b). The DNA sequences have been deposited in
GenBankTM (GenBankTM accession numbers
AF329442-329445). The derived amino acid sequences (Fig.
1b) indicate that these peptides are homologs of
-ACTX-Hv2a and reveal that the mature toxins are obtained by
processing of a much larger prepropeptide precursor. The propeptide cleavage site was readily discerned from the known N-terminal sequence
of -ACTX-Hv2a and -ACTX-Hi2a, whereas the signal peptide cleavage
site was predicted using SignalP (20).
The prepropeptide architecture is similar to that determined for
conotoxins (21, 22) and provides the first circumstantial evidence that
Australian funnel-web spiders have evolved a strategy similar to that
of the cone snails for diversifying their toxin pool. The signal
sequence is extremely well conserved (78% identity and 100%
similarity if conservative substitutions are included; see Fig.
1b), whereas the mature peptide sequence is more diversified (53% identity). This finding is consistent with accelerated evolution (hypermutation) of the C-terminal region of the precursor to generate a
library of functionally diverse toxins with identical cystine framework
(21, 22). It will be interesting in future studies to directly examine
whether the venom contains families of functionally disparate toxins
with the same signal sequence.
Mass spectral analysis of -ACTX-Hi2a (predicted oxidized
mass = 4408 Da; observed mass = 4009 Da) indicated that it
undergoes posttranslational deletion of the C-terminal four residues.
C-terminal "trimming" has been noted for several spider (23, 24)
and scorpion (25) toxins. The scorpion toxin AaH II from
Androctonus australis Hector undergoes posttranslational
cleavage at a C-terminal Gly-Arg followed by an amidation process that
eliminates the C-terminal glycine (25). Similar processing at the
C-terminal Gly-Arg sequence in the H. infensa toxins would
yield a toxin with the experimentally observed mass and would explain
the block encountered during C-terminal sequencing of -ACTX-Hi2a.
Mass analysis of the H. versuta and Atrax toxins
indicated that their C termini are not trimmed, consistent with the
absence of the C-terminal Gly-Arg sequence.
-ACTX-Hv2a Is a Potent and Specific Blocker of Insect Calcium
Channels--
Application of -ACTX-Hv2a (10 pM to 100 nM) to bee brain neurons inhibited calcium channel currents
(ICa) in all cells examined (n = 37; Fig. 2a), with maximum
inhibition occurring at concentrations of >10 nM. The
EC50 for -ACTX-Hv2a inhibition of
ICa was ~130 pM (Fig.
2c). Inhibition was rapid at high concentrations and was not
significantly reversed by prolonged washing (Fig. 2d). Application of -agatoxin (Aga)-IVA, the prototypic antagonist of
vertebrate P-type voltage-gated calcium channels (26), also inhibited
ICa in all bee neurons examined
(n = 19), but the EC50 (10 nM)
and the concentration required for maximum inhibition (>100
nM) were both significantly higher than those for
-ACTX-Hv2a (Fig. 2c).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
-ACTX-Hv2a is a specific
antagonist of insect voltage-gated calcium channels. a,
whole cell calcium channel currents (ICa)
recorded from a bee brain neuron in the absence (control) or presence
of -ACTX-Hv2a. b, whole cell calcium channel currents
recorded from a bee brain neuron in the absence (control) or presence
of CT-Hv2a. c, dose-response curves for inhibition of
ICa in bee brain and rat trigeminal neurons by
-ACTX-Hv2a ( and ) and -Aga-IVA ( and ). Each data
point is the mean ± S.D. of 7-10 recordings. The curves are the
result of fitting a simple logistic function to the data. d,
time course for inhibition of ICa recorded from
a bee brain neuron after the addition of 1 and 10 nM
-ACTX-Hv2a at the indicated times. Inhibition was rapid and was not
significantly reversed by prolonged washing (indicated by the
horizontal bar).
|
|
In striking contrast to its effect on invertebrate neurons, superfusion
of high concentrations of -ACTX-Hv2a (1 µM;
n = 10) for 5 min had little effect on
ICa in mouse sensory neurons, whereas application of -Aga-IVA inhibited a component of
ICa in all mouse sensory neurons with an
EC50 of about 20 nM (maximum
ICa inhibition ~40%; Fig. 2c).
-ACTX-Hv2a (100 nM) did not inhibit the
tetrodotoxin-sensitive INa of bee brain neurons
(INa was 98 ± 4% of control;
n = 4), nor did it significantly affect
INa in mouse sensory neurons
(INa was 97 ± 3% of control with
-ACTX-Hv2a = 1 µM; n = 5).
-ACTX-Hv2a (100 nM; n = 5) had no effect
on bee brain IK at any potential when neurons
were stepped from 90 mV to between 40 and +60 mV.
We conclude that -ACTX-Hv2a is a potent and extremely specific
blocker of insect voltage-gated calcium channels. Based on the data in
Fig. 2c, we calculate that -ACTX-Hv2a has at least a
10,000-fold preference for insect versus vertebrate calcium channels.
Three-dimensional Structure of -ACTX-Hv2a--
The solution
structure of -ACTX-Hv2a purified from H. versuta venom
was determined using standard homonuclear NMR methods (16). The
ensemble of structures (Fig. 3; Table
I; Protein Data Bank accession code 1G9P)
is highly precise with a backbone r.m.s. difference of 0.18 Å for the structured region (residues 3-32). According to PROCHECK (27),
75% of the non-Pro/Gly residues in the structured region lie in most
favored sector of the Ramachandran plot, with the remaining 25%
located in "additionally allowed" regions.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Solution structure of
-ACTX-Hv2a. a, ensemble of 20 -ACTX-Hv2a structures superimposed for best fit over the backbone
atoms of residues 3-32 of the mean coordinate structure. Disulfide
bonds are shown in red, and the backbone is colored
green (310-helix), gold
( -strands), or blue. Note the unstructured C-terminal
domain (residues 33-45). b, stereo view of the globular
disulfide-rich domain (residues 1-32) with the same molecular
orientation and color scheme as described in a. Disulfide
bridges are labeled.
|
|
The disulfide-rich region of -ACTX-Hv2a (residues 3-32) is
organized into a compact globular domain containing a small stretch of
310-helix (residues 13-17), a short -hairpin (residues
23-30, comprising -strands at residues 23-25 and 28-30), and well
defined -turns at residues 18-21 (type I) and 25-28 (type I')
(Fig. 3b). This globular domain contains a small hydrophobic
core formed by two buried disulfide bridges (17-29 and 11-24) and the
side chain of Thr-21. In striking contrast to the highly ordered
disulfide-rich core, the N-terminal two residues and the entire
lipophilic C-terminal tail (residues 33-45) are disordered in solution
(Fig. 3a).
The three disulfide bridges in -ACTX-Hv2a form an inhibitory cystine
knot motif (28) in which the Cys-17-Cys-29 disulfide passes through a
15-residue ring formed by the other two disulfide bridges and the
intervening sections of polypeptide backbone (Fig. 3b).
Although the N-terminal disulfide bridge of the inhibitory cystine knot
motif does not generally contribute to the hydrophobic core of
inhibitory cystine knot toxins and is not essential for formation of
the basic inhibitory cystine knot fold (6, 29), a complete cystine knot
motif has been found in all four atracotoxin structures reported to
date (this study and Refs. 6, 9, and 11). Presumably, the additional
stability and protease resistance conferred by the complete knot (28)
are critical for effective delivery of these neurotoxins to their sites
of action.
Structural/Functional Homology with -Agatoxin-IVA--
A search
of the protein structure database using DALI (30) revealed weak but
functionally significant structural homology between -ACTX-Hv2a and
-Aga-IVA from the unrelated American funnel-web spider
Agelenopsis aperta (Fig.
4a). We previously noted close
structural/functional homology between the sodium channel modifiers
-ACTX from H. versuta and µ-Aga-I from A. aperta (6, 9). Given the large evolutionary distance between these arachnids (Australian funnel-web spiders are primitive mygalomorphs, whereas American funnel-web spiders are modern araneomorphs), these
results imply a remarkable case of convergent evolution.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
a, overlay of -ACTX-Hv2a
(gold) on -Aga-IVA (green; Protein Data Bank
accession code 1OAW); the core disulfide bridges of each toxin are
shown as red and sage tubes, respectively. A
similar comparison can be made with -Aga-IVB (Protein Data Bank
accession code 1AGG). The folds are homologous, but loops 1 and 3 are
more highly elaborated in -Aga-IVA/B. The molecules are rotated
~180° around the long axis of the -hairpin relative to the view
in Fig. 3. b, the mean 20 CT-Hv2a structure
(cyan) superimposed for best fit over the backbone of
residues 3-32 of the mean -ACTX-Hv2a structure (gold).
The molecular orientation is similar to that in Fig. 3. c,
hypothetical models of the mechanism of action of -ACTX-Hv2a and
-Aga-IVA in which the lipophilic C-terminal tail (orange)
penetrates the lipid bilayer either adjacent to the channel (top
panel) or by intercalation between transmembrane segments of the
calcium channel (bottom panel). In either case, this
positions the disulfide-rich core (shaded sphere) for direct
interaction with the extracellular surface of the channel.
|
|
In addition to the significant structural homology between the
disulfide-rich domains of -ACTX-Hv2a and -Aga-IVA, both toxins have an unstructured, lipophilic C-terminal extension that was demonstrated to be critical for the activity of -Aga-IVA (31). To
examine the functional role of the unstructured C-terminal domain in
-ACTX-Hv2a (i.e. residues 33-45), we produced a
synthetic peptide comprising only residues 1-32 of the parent toxin
and determined its solution structure using NMR spectroscopy (Table I;
Protein Data Bank accession code 1HP3). As expected, the truncated
toxin has the same fold as the corresponding region of the full-length
parent toxin (Fig. 4b). However, we found that the
C-terminally truncated toxin did not inhibit insect calcium channels
(Fig. 2b), nor did it competitively inhibit the activity of
the native toxin (data not shown). Thus, we conclude that the lipophilic C-terminal extension is essential for interaction of -ACTX-Hv2a with insect calcium channels.
 |
DISCUSSION |
Insecticide Development--
Most commonly used insecticides
target voltage-gated sodium channels (e.g. DDT,
pyrethroids), GABA receptors (e.g. cyclodienes and
fipronil), or acetylcholinesterase (e.g. organophosphorus and carbamate insecticides) (32). This narrow target range has accelerated resistance development (1) and stimulated interest in the
elucidation of new insecticidal compounds that act on novel targets. We
have shown in this study that -ACTX-Hv2a acts on a nonconventional
target, namely, insect voltage-gated calcium channels. Furthermore,
this toxin appears to be the most potent blocker of these channels
reported to date; its EC50 on bee brain neurons (~130
pM; this study) is significantly lower than that obtained
for -Aga-IVA on bee (~10 nM; this study) or cockroach (17 nM; Ref. 33) brain neurons.
The unprecedented phylogenetic specificity of -ACTX-Hv2a
significantly augments its utility as a lead compound for insecticide development, with our studies indicating that the toxin has at least a
10,000-fold preference for insect over vertebrate calcium channels.
Whereas the toxin was inactive in all vertebrates tested in this
study (chicken, rat, and mouse), we have found that
-ACTX-Hv2a is toxic to a wide range of insect orders, including
Leptidoptera, Diptera, and
Orthoptera.2 PLTX-II
appears to be the only peptide toxin with comparable potency on insect
calcium channels (34), but its ion channel and phylogenetic specificity
remains to be determined.
Mode of Action--
Surprisingly, despite a complete lack of
sequence similarity, we found that -ACTX-Hv2a has weak but
functionally significant structural homology with -Aga-IVA/B from
the American funnel-web spider A. aperta. Both toxins
contain a highly ordered disulfide-rich core and an unstructured
lipophilic C-terminal region that protrudes from this globular domain.
Both toxins have markedly reduced activity when the lipophilic
C-terminal extension is deleted. Furthermore, we demonstrated that
C-terminally truncated -ACTX-Hv2a does not competitively inhibit the
activity of the full-length toxin, suggesting that the disulfide-rich
core does not bind the channel in the absence of the C-terminal tail.
These results lead us to propose a possible model for the mode of
action of these toxins.
It seems improbable that the structurally disordered C-terminal tails
of -ACTX-Hv2a and -Aga-IVA make specific interactions with
residues on the extracellular surface of voltage-gated calcium channels. First, it is difficult to envisage how these lipophilic tails
could make extensive favorable contacts with the largely polar surface
of the channel. Second, the C-terminal apolar tail of -ACTX-Hv2a is
a low complexity sequence, comprising a triple (G/P)G(L/I)(L/V) repeat,
which seems unlikely to make specific high-affinity contacts with the
channel surface. Third, in this model, immobilization of the C-terminal
tail upon channel binding would incur a huge loss of conformational
entropy, which is difficult to reconcile with EC50 values
in the picomolar range.
Thus, we suggest that -ACTX-Hv2a and -Aga-IVA share a similar
mechanism of action in which the lipophilic tail does not make specific
high-affinity contacts with the extracellular surface of the targeted
calcium channel but rather initiates toxin binding by
penetrating the membrane either adjacent to the channel or by
intercalation between transmembrane segments of the channel protein
(Fig. 4c). A similar model has been proposed for the mode of
action of -Aga-IVB (35). Limited motion of the tail region within
the membrane might minimize the loss of conformational entropy suffered
by the toxin upon channel binding. We propose that anchoring of the
C-terminal tail in the membrane somehow facilitates direct interaction
of the disulfide-rich core region with the extracellular surface of the
channel (i.e. the tail "targets" the structured region
to the channel). One possibility is that binding of the C-terminal tail
alters the channel conformation sufficiently to reveal a cryptic
high-affinity binding site for the disulfide-rich portion of the toxin.
In this model, C-terminal truncates would not be expected to bind the
channel or act as competitive inhibitors of the wild-type toxin, which
is what we observed experimentally.
While further experiments will clearly be required to test this
hypothesis, it is salient to note that the insect calcium channel
blocker PLTX-II from the spider Plectreurys tristis contains a C-terminal palmitoyl group that is essential for biological activity
(36), and therefore it may function similarly. Thus, it will be
instructive in future experiments to examine whether the C-terminal
tail of -ACTX-Hv2a can be replaced by nonspecific hydrophobic
anchors such as a palmitoyl group.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Mark Maciejewski, Roger
Drinkwater, and Benjamin Oldroyd for help with NMR data
acquisition, RACE analysis, and bee collection, respectively.
 |
FOOTNOTES |
*
This work was supported by National Science Foundation Grant
MCB9983242 (to G. F. K.), Australian Research Council grants (to
G. M. N., M. J. C., and G. F. K.), and Postgraduate Research Scholarships (to X.-h. W., D. W., and H. I. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The amino acid sequence reported in this paper has been submitted
to the Swiss Protein Database under Swiss-Prot accession no.
P82852.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF329442-AF329445.
The atomic coordinates and NMR restraints (code 1G9P and 1HP3)
have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ
(http://www.rcsb.org/).
The 1H NMR chemical shifts for this protein are
available in the BioMagResBank under BMRB accession no. 4923.
¶¶
To whom correspondence should be addressed: Dept. of
Biochemistry, MC3305, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06032. Tel.: 860-679-8364; Fax:
860-679-1652; E-mail: glenn@psel.uchc.edu.
Published, JBC Papers in Press, August 24, 2001, DOI 10.1074/jbc.M105206200
2
B. L. Sollod and G. F. King, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
rpHPLC, reverse
phase high pressure liquid chromatography;
ACTX, atracotoxin;
RACE, rapid amplification of cDNA ends;
NOE, nuclear Overhauser
enhancement;
Aga, agatoxin;
r.m.s., root mean square;
NOESY, NOE
spectroscopy;
TOSCY, total correlation spectroscopy;
ECOSY, exclusion
correlation spectroscopy;
PLTX, Plectreurys tristes
toxin.
 |
REFERENCES |
| 1.
|
Feyereisen, R.
(1995)
Toxicol. Lett.
82-83,
83-90
|
| 2.
|
Betarbet, R.,
Sherer, T. B.,
MacKenzie, G.,
Garcia-Osuna, M.,
Panov, A. V.,
and Greenamyre, J. T.
(2000)
Nat. Neurosci.
3,
1301-1306[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Shelton, A. M.,
Tang, J. D.,
Roush, R. T.,
Metz, T. D.,
and Earle, E. D.
(2000)
Nat. Biotechnol.
18,
339-342[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Cory, J. S.,
Hirst, M. L.,
Williams, T.,
Hails, R. S.,
Goulson, D.,
Green, B. M.,
Carty, T. M.,
Possee, R. D.,
Cayley, P. J.,
and Bishop, D. H. L.
(1994)
Nature
370,
138-140[CrossRef]
|
| 5.
|
Bonning, B. C.,
and Hammock, B. D.
(1996)
Annu. Rev. Entomol.
41,
191-210[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Wang, X.-H.,
Connor, M.,
Smith, R.,
Maciejewski, M. W.,
Howden, M. E. H.,
Nicholson, G. M.,
Christie, M. J.,
and King, G. F.
(2000)
Nat. Struct. Biol.
7,
505-513[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Wang, X.-H.,
Smith, R.,
Fletcher, J. I.,
Wilson, H.,
Wood, C. J.,
Howden, M. E. H.,
and King, G. F.
(1999)
Eur. J. Biochem.
264,
488-494[Medline]
[Order article via Infotrieve]
|
| 8.
|
Szeto, T. H.,
Wang, X.-H.,
Smith, R.,
Connor, M.,
Christie, G. M.,
Nicholson, G. M.,
and King, G. F.
(1999)
Toxicon
38,
429-442[CrossRef]
|
| 9.
|
Fletcher, J. I.,
Chapman, B. E.,
Mackay, J. P.,
Howden, M. E. H.,
and King, G. F.
(1997)
Structure
5,
1525-1535[Medline]
[Order article via Infotrieve]
|
| 10.
|
Hamill, O. P.,
Marty, A.,
Neher, E.,
Sakmann, B.,
and Sigworth, F. J.
(1981)
Eur. J. Physiol.
391,
85-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Fletcher, J. I.,
Smith, R.,
O'Donoghue, S. I.,
Nilges, M.,
Connor, M.,
Howden, M. E. H.,
Christie, M. J.,
and King, G. F.
(1997)
Nat. Struct. Biol.
4,
559-566[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Fletcher, J. I.,
Dingley, A. J.,
Smith, R.,
Connor, M.,
Christie, M. J.,
and King, G. F.
(1999)
Eur. J. Biochem.
264,
525-533[Medline]
[Order article via Infotrieve]
|
| 13.
|
Bartels, C.,
Xia, T.-H.,
Billeter, M.,
Güntert, P.,
and Wüthrich, K.
(1995)
J. Biomol. NMR
5,
1-10[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Güntert, P.,
Mumenthaler, C.,
and Wüthrich, K.
(1997)
J. Mol. Biol.
273,
283-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Ludvigsen, S.,
and Poulsen, F. M.
(1992)
J. Biomol. NMR
2,
227-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Wüthrich, K.
(1986)
NMR of Proteins and Nucleic Acids
, John Wiley & Sons, Inc., New York
|
| 17.
|
Brünger, A. T.
(1992)
X-PLOR Version 3.1
, Yale University Press, New Haven, CT
|
| 18.
|
Koradi, R.,
Billeter, M.,
and Wüthrich, K.
(1996)
J. Mol. Graph.
14,
51-55[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Frohman, M. A.
(1993)
Methods Enzymol.
218,
340-356[Medline]
[Order article via Infotrieve]
|
| 20.
|
Nielsen, H.,
Engelbrecht, J.,
Brunak, S.,
and von Heijne, G.
(1997)
Protein Eng.
10,
1-6[Abstract/Free Full Text]
|
| 21.
|
Olivera, B. M.,
Hillyard, D. R.,
Marsh, M.,
and Yoshikami, D.
(1995)
Trends Biotechnol.
13,
422-426[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Olivera, B. M.,
and Cruz, L. J.
(2001)
Toxicon
39,
7-14[Medline]
[Order article via Infotrieve]
|
| 23.
|
Diniz, M. R.,
Paine, M. J.,
Diniz, C. R.,
Theakston, R. D.,
and Crampton, J. M.
(1993)
J. Biol. Chem.
268,
15340-15342[Abstract/Free Full Text]
|
| 24.
|
Leisy, D. J.,
Mattson, J. D.,
Quistad, G. B.,
Kramer, S. J.,
Van Beek, N.,
Tsai, L. W.,
Enderlin, F. E.,
Woodworth, A. R.,
and Digan, M. E.
(1996)
Insect Biochem. Mol. Biol.
26,
411-417[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Bougis, P. E.,
Rochat, H.,
and Smith, L. A.
(1989)
J. Biol. Chem.
264,
19259-19265[Abstract/Free Full Text]
|
| 26.
|
Mintz, I. M.,
Venema, V. J.,
Swiderek, K. M.,
Lee, T. D.,
Bean, B. P.,
and Adams, M. E.
(1992)
Nature
355,
827-829[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Laskowski, R. A.,
MacArthur, M. W.,
Moss, D. S.,
and Thornton, J. M.
(1993)
J. Appl. Crystallogr.
26,
283-291[CrossRef]
|
| 28.
|
Craik, D. J.,
Daly, N. L.,
and Waine, C.
(2001)
Toxicon
39,
43-60[Medline]
[Order article via Infotrieve]
|
| 29.
|
Le-Nguyen, D.,
Heitz, A.,
Chiche, L.,
El Hajji, M.,
and Castro, B.
(1993)
Protein Sci.
2,
165-174[Medline]
[Order article via Infotrieve]
|
| 30.
|
Holm, L.,
and Sander, C.
(1993)
J. Mol. Biol.
233,
123-138[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Kim, J. I.,
Konishi, S.,
Iwai, H.,
Kohno, T.,
Gouda, H.,
Shimada, I.,
Sato, K.,
and Arata, Y.
(1995)
J. Mol. Biol.
250,
659-671[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
French-Constant, R. H.,
Pittendringh, B.,
Vaughan, A.,
and Anthony, N.
(1998)
Philos. Trans. R. Soc. Lond. B. Biol. Sci.
353,
1685-1693[Abstract/Free Full Text]
|
| 33.
|
Benquet, P.,
Le Guen, J.,
Dayanithi, Y.,
Pichon, Y.,
and Tiaho, F.
(1999)
J. Neurophysiol.
82,
2284-2293[Abstract/Free Full Text]
|
| 34.
|
Leung, H.-T.,
Branton, W. D.,
Phillips, H. S.,
Jan, L.,
and Byerly, L.
(1989)
Neuron
3,
767-772[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Yu, H.,
Rosen, M. K.,
Saccomano, N. A.,
Phillips, D.,
Volkmann, R. A.,
and Schreiber, S. L.
(1993)
Biochemistry
32,
13123-13129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Branton, W. D.,
Rudnick, M. S.,
Zhou, Y.,
Eccleston, E. D.,
Fields, G. B.,
and Bowers, L. D.
(1993)
Nature
365,
496-497[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|